Abstract
Tobacco addiction is one of the leading causes of preventable death worldwide. Despite the negative health outcomes of tobacco use and a desire to quit, there is a low success rate of maintaining abstinence. Nicotine, the main psychoactive component of tobacco smoke, is mildly rewarding and maintains smoking behavior. Nicotine withdrawal induces somatic symptoms that may contribute to smoking behavior. However, it has been hypothesized that the negative affective signs are of greater motivational significance in contributing to relapse and continued tobacco use than the somatic symptoms of nicotine withdrawal (Markou and Koob (Eds.) Intracranial self-stimulation thresholds as a measure of reward, Vol. 2, Oxford University Press, New York, 1993; Koob et al. Semin Neurosci 5: 351–358, 1993). Intracranial self-stimulation (ICSS) has been established as a method to assess the bivalent properties of nicotine exposure and withdrawal from acute and chronic nicotine administration. Thus, ICSS provides a means to measure the negative affective aspects of nicotine withdrawal in animal models and may contribute to the understanding of the neurobiological bases of nicotine dependence and the development of effective treatment strategies to facilitate nicotine abstinence.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Markou, A., and Koob, G., (Eds.) (1993) Intracranial self-stimulation thresholds as a measure of reward, Vol. 2, Oxford University Press, New York.
Koob, G., Markou, A., Weiss, F., and Schulteis, G. (1993) Opponent process and drug dependence: Neurobiological mechanisms, Semin Neurosci 5, 351–358.
Volkow, N. (2009) Tobacco Addiction, in Research Report, National Institute on Drug Abuse, Rockville, MD.
(2009) Results from the 2008 National Survey on Drug Use and Health: National Findings Substance Abuse and Mental Health Services Administration, Rockville, MD.
Le Foll, B., and Goldberg, S. R. (2009) Effects of nicotine in experimental animals and humans: an update on addictive properties, Handb Exp Pharmacol, 335–367.
Benowitz, N. L. (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics, Annu Rev Pharmacol Toxicol 49, 57–71.
Anthony, J. C., Warner, L. A., and Kessler, R. C. (1994) Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled Substances, and Inhalants: Basic Findings From the National Comorbidity Survey, Experimental and Clinical Psychopharmacology 2, 244–268.
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A., and Sved, A. F. (2001) Cue dependency of nicotine self-administration and smoking, Pharmacol Biochem Behav 70, 515–530.
Hughes, J. R., Gust, S. W., Skoog, K., Keenan, R. M., and Fenwick, J. W. (1991) Symptoms of tobacco withdrawal. A replication and extension, Arch Gen Psychiatry 48, 52–59.
Hughes, J. R., and Hatsukami, D. (1986) Signs and symptoms of tobacco withdrawal, Arch Gen Psychiatry 43, 289–294.
Hughes, J. R. (2006) Clinical significance of tobacco withdrawal, Nicotine Tob Res 8, 153–156.
Wesnes, K., and Warburton, D. M. (1983) Smoking, nicotine and human performance, Pharmacol Ther 21, 189–208.
Bruijnzeel, A. W., and Gold, M. S. (2005) The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence, Brain Res Brain Res Rev 49, 505–528.
Koob, G. F. (2008) A role for brain stress systems in addiction, Neuron 59, 11–34.
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., and Markou, A. (1998) Dramatic decreases in brain reward function during nicotine withdrawal, Nature 393, 76–79.
Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., Hebert, K. M., Conrad, D. L., and Wilson, O. B. (1994) The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat, Psychopharmacology (Berl) 115, 180–184.
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., and Wilson, O. B. (1992) Rodent model of nicotine abstinence syndrome, Pharmacol Biochem Behav 43, 779–784.
Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., and Svensson, T. H. (1997) Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms, Psychopharmacology (Berl) 129, 348–356.
Paterson, N. E. (2009) The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine, Behav Pharmacol 20, 211–225.
Nakahara, D. (2004) Influence of nicotine on brain reward systems: study of intracranial self-stimulation, Ann NY Acad Sci 1025, 489–490.
Bespalov, A., Lebedev, A., Panchenko, G., and Zvartau, E. (1999) Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats, Eur Neuropsychopharmacol 9, 377–383.
Markou, A., and Koob, G. F. (1991) Postcocaine anhedonia. An animal model of cocaine withdrawal, Neuropsychopharmacology 4, 17–26.
Lin, D., Koob, G. F., and Markou, A. (1999) Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat – interactions between the two drugs, Psychopharmacology (Berl) 145, 283–294.
Schulteis, G., Markou, A., Gold, L. H., Stinus, L., and Koob, G. F. (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis, J Pharmacol Exp Ther 271, 1391–1398.
Schulteis, G., Markou, A., Cole, M., and Koob, G. F. (1995) Decreased brain reward produced by ethanol withdrawal, Proc Natl Acad Sci USA 92, 5880–5884.
Leith, N. J., and Barrett, R. J. (1976) Amphetamine and the reward system: evidence for tolerance and post-drug depression, Psychopharmacologia 46, 19–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bauzo, R.M., Bruijnzeel, A.W. (2012). Animal Models of Nicotine Withdrawal: Intracranial Self-Stimulation and Somatic Signs of Withdrawal. In: Kobeissy, F. (eds) Psychiatric Disorders. Methods in Molecular Biology, vol 829. Humana Press. https://doi.org/10.1007/978-1-61779-458-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-458-2_16
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-457-5
Online ISBN: 978-1-61779-458-2
eBook Packages: Springer Protocols